Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 9, Issue 9, Pages 1289-1305
Publisher
Informa UK Limited
Online
2009-09-21
DOI
10.1586/ern.09.88
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
- (2009) Albert Fournier et al. Expert Review of Neurotherapeutics
- Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply
- (2009) Salim Yusuf et al. LANCET
- (Pro)renin receptors: are they biologically relevant?
- (2008) AH Jan Danser CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Physiology and pharmacology of the (pro)renin receptor
- (2008) G NGUYEN et al. CURRENT OPINION IN PHARMACOLOGY
- Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks
- (2008) Toshio Ogihara et al. HYPERTENSION
- Blood pressure lowering with fixed combination perindopril???indapamide: key findings from ADVANCE
- (2008) John Chalmers et al. JOURNAL OF HYPERTENSION
- Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors
- (2008) Sebastien Faure et al. JOURNAL OF HYPERTENSION
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis
- (2008) Gianpaolo Reboldi et al. JOURNAL OF HYPERTENSION
- Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies
- (2008) Hao Liu et al. JOURNAL OF HYPERTENSION
- Thrombolytics for PE and right ventricular dysfunction
- (2008) Syed Wamique Yusuf et al. LANCET
- From angiotensin IV binding site to AT4 receptor
- (2008) Patrick M.L. Vanderheyden MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Hypertension in Patients 80 Years of Age or Older
- (2008) Nigel S. Beckett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
- (2008) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
- (2008) Kenneth Jamerson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targets
- (2007) J WRIGHT et al. PROGRESS IN NEUROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started